Home
PBYI
PBYI News

Latest Puma Biotechnology Inc (PBYI) News on May 9, 2025

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

3 days ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?

Zacks

4 days ago

ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?

Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients

GlobeNewswire

9 days ago

Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients

Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025

Business Wire

11 days ago

Puma Biotechnology Presents Clinical Data on Neratinib at the AACR Annual Meeting 2025

Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results

Business Wire

15 days ago

Puma Biotechnology to Host Conference Call to Discuss First Quarter 2025 Financial Results

Should Value Investors Buy Puma Biotechnology (PBYI) Stock?

Zacks

16 days ago

Should Value Investors Buy Puma Biotechnology (PBYI) Stock?

Is the Options Market Predicting a Spike in Puma Biotechnology Stock?

Zacks

18 days ago

Is the Options Market Predicting a Spike in Puma Biotechnology Stock?

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a month ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology, Inc. (NASDAQ:PBYI) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Simply Wall St.

a month ago

Puma Biotechnology, Inc. (NASDAQ:PBYI) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025

Business Wire

a month ago

Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025

Puma Biotechnology Stock Rises 35% in 6 Months: Here's Why

Zacks

2 months ago

Puma Biotechnology Stock Rises 35% in 6 Months: Here's Why

Puma Biotechnology (PBYI): One of the Best Short-Term Stocks to Buy Right Now

Insider Monkey

2 months ago

Puma Biotechnology (PBYI): One of the Best Short-Term Stocks to Buy Right Now

We Think Puma Biotechnology's (NASDAQ:PBYI) Healthy Earnings Might Be Conservative

Simply Wall St.

2 months ago

We Think Puma Biotechnology's (NASDAQ:PBYI) Healthy Earnings Might Be Conservative

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

2 months ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference

Business Wire

2 months ago

Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference

Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now?

Zacks

2 months ago

Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now?

Results: Puma Biotechnology, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Simply Wall St.

2 months ago

Results: Puma Biotechnology, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Thomson Reuters StreetEvents

2 months ago

Q4 2024 Puma Biotechnology Inc Earnings Call

PBYI Stock Rises as Q4 Earnings & Sales Outpace Estimates

Zacks

2 months ago

PBYI Stock Rises as Q4 Earnings & Sales Outpace Estimates

GoodRx Holdings Leads The Charge With These 3 Promising Penny Stocks

Simply Wall St.

2 months ago

GoodRx Holdings Leads The Charge With These 3 Promising Penny Stocks

GuruFocus.com

2 months ago

Puma Biotechnology Inc (PBYI) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ...

Associated Press Finance

2 months ago

Puma Biotech: Q4 Earnings Snapshot

Puma Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results

Business Wire

2 months ago

Puma Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results

Puma Biotechnology to Present at TD Cowen’s 45th Annual Health Care Conference

Business Wire

2 months ago

Puma Biotechnology to Present at TD Cowen’s 45th Annual Health Care Conference

Investors in Puma Biotechnology (NASDAQ:PBYI) have unfortunately lost 73% over the last five years

Simply Wall St.

3 months ago

Investors in Puma Biotechnology (NASDAQ:PBYI) have unfortunately lost 73% over the last five years

Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results

Business Wire

3 months ago

Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

3 months ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

US Penny Stocks To Watch In January 2025

Simply Wall St.

3 months ago

US Penny Stocks To Watch In January 2025

Is Now The Time To Put Puma Biotechnology (NASDAQ:PBYI) On Your Watchlist?

Simply Wall St.

4 months ago

Is Now The Time To Put Puma Biotechnology (NASDAQ:PBYI) On Your Watchlist?

Best Value Stocks to Buy for January 6th

Zacks

4 months ago

Best Value Stocks to Buy for January 6th

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

4 months ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Is Puma Biotechnology (PBYI) Stock Undervalued Right Now?

Zacks

4 months ago

Is Puma Biotechnology (PBYI) Stock Undervalued Right Now?

US Penny Stocks With Promise: 3 Picks Under $200M Market Cap

Simply Wall St.

4 months ago

US Penny Stocks With Promise: 3 Picks Under $200M Market Cap

Puma Biotechnology Stock Rises 24% in 3 Months: Here's Why

Zacks

4 months ago

Puma Biotechnology Stock Rises 24% in 3 Months: Here's Why

Is Bristol Myers Squibb (BMY) Stock Undervalued Right Now?

Zacks

4 months ago

Is Bristol Myers Squibb (BMY) Stock Undervalued Right Now?

Best Momentum Stocks to Buy for December 24th

Zacks

4 months ago

Best Momentum Stocks to Buy for December 24th

Best Value Stocks to Buy for December 24th

Zacks

5 months ago

Best Value Stocks to Buy for December 24th

With 49% stake, Puma Biotechnology, Inc. (NASDAQ:PBYI) seems to have captured institutional investors' interest

Simply Wall St.

5 months ago

With 49% stake, Puma Biotechnology, Inc. (NASDAQ:PBYI) seems to have captured institutional investors' interest

Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation

Business Wire

5 months ago

Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Zacks

5 months ago

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

5 months ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Should Value Investors Buy Puma Biotechnology (PBYI) Stock?

Zacks

5 months ago

Should Value Investors Buy Puma Biotechnology (PBYI) Stock?

Discovering Promising US Penny Stocks In November 2024

Simply Wall St.

5 months ago

Discovering Promising US Penny Stocks In November 2024

PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer

Zacks

6 months ago

PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer

Puma commences Phase II trial of alisertib for breast cancer treatment

Clinical Trials Arena

6 months ago

Puma commences Phase II trial of alisertib for breast cancer treatment

MT Newswires

6 months ago

Puma Biotechnology Launches Mid-Stage Trial of Alisertib to Treat Breast Cancer

Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

Business Wire

6 months ago

Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative

Simply Wall St.

6 months ago

We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative

Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

6 months ago

Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations

PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up

Zacks

6 months ago

PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up

GuruFocus.com

6 months ago

Puma Biotechnology Inc (PBYI) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ...

Associated Press Finance

6 months ago

Puma Biotech: Q3 Earnings Snapshot

Puma Biotechnology Reports Third Quarter 2024 Financial Results

Business Wire

6 months ago

Puma Biotechnology Reports Third Quarter 2024 Financial Results

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

6 months ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

3 US Penny Stocks With Market Caps Under $700M

Simply Wall St.

6 months ago

3 US Penny Stocks With Market Caps Under $700M

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results

Business Wire

6 months ago

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results

With A Return On Equity Of 18%, Has Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Management Done Well?

Simply Wall St.

7 months ago

With A Return On Equity Of 18%, Has Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Management Done Well?

Puma Biotechnology (NASDAQ:PBYI) investors are sitting on a loss of 79% if they invested five years ago

Simply Wall St.

8 months ago

Puma Biotechnology (NASDAQ:PBYI) investors are sitting on a loss of 79% if they invested five years ago

Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Business Wire

8 months ago

Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

MT Newswires

9 months ago

Federal Judge Rejects Patent Claims Supporting Puma Biotechnology's Breast Cancer Drug; Company Shares Down After Hours

Puma Biotechnology's (NASDAQ:PBYI) Earnings Offer More Than Meets The Eye

Simply Wall St.

9 months ago

Puma Biotechnology's (NASDAQ:PBYI) Earnings Offer More Than Meets The Eye

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

9 months ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

9 months ago

Puma Biotechnology Second Quarter 2024 Earnings: Beats Expectations

Analysts Have Been Trimming Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target After Its Latest Report

Simply Wall St.

9 months ago

Analysts Have Been Trimming Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target After Its Latest Report

Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected

Zacks

9 months ago

Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected

Zacks.com featured highlights Abercrombie & Fitch, Puma Biotechnology, Spotify and Oddity

Zacks

9 months ago

Zacks.com featured highlights Abercrombie & Fitch, Puma Biotechnology, Spotify and Oddity

Associated Press Finance

9 months ago

Puma Biotech: Q2 Earnings Snapshot

Puma Biotechnology Reports Second Quarter Financial Results

Business Wire

9 months ago

Puma Biotechnology Reports Second Quarter Financial Results

Should Value Investors Buy Puma Biotechnology (PBYI) Stock?

Zacks

10 months ago

Should Value Investors Buy Puma Biotechnology (PBYI) Stock?

Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results

Business Wire

10 months ago

Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

10 months ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge

Bloomberg

a year ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a year ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer

Business Wire

a year ago

Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer

Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)

Business Wire

a year ago

Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)

Puma Biotechnology to Join Russell 3000 Index

Business Wire

a year ago

Puma Biotechnology to Join Russell 3000 Index

With 49% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) has piqued the interest of institutional investors

Simply Wall St.

a year ago

With 49% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) has piqued the interest of institutional investors

Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why

Zacks

a year ago

Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why

Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting

Business Wire

a year ago

Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting

Implied Volatility Surging for Puma Biotechnology (PBYI) Stock Options

Zacks

a year ago

Implied Volatility Surging for Puma Biotechnology (PBYI) Stock Options

Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results

Simply Wall St.

a year ago

Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results

Puma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a year ago

Puma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript

Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat

Zacks

a year ago

Puma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat

GuruFocus.com

a year ago

Puma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...

Puma Biotechnology Inc (PBYI) Reports Q1 Financial Results, Misses Analyst Revenue and EPS Forecasts

GuruFocus.com

a year ago

Puma Biotechnology Inc (PBYI) Reports Q1 Financial Results, Misses Analyst Revenue and EPS Forecasts

Associated Press Finance

a year ago

Puma Biotech: Q1 Earnings Snapshot

Puma Biotechnology Reports First Quarter Financial Results

Business Wire

a year ago

Puma Biotechnology Reports First Quarter Financial Results

Is Puma Biotechnology, Inc. (NASDAQ:PBYI) A High Quality Stock To Own?

Simply Wall St.

a year ago

Is Puma Biotechnology, Inc. (NASDAQ:PBYI) A High Quality Stock To Own?

What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings?

Zacks

a year ago

What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings?

Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results

Business Wire

a year ago

Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results

Puma Biotechnology (NASDAQ:PBYI) shareholders have earned a 93% return over the last year

Simply Wall St.

a year ago

Puma Biotechnology (NASDAQ:PBYI) shareholders have earned a 93% return over the last year

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a year ago

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Share on Social Networks: